Drug Co. Manager Pleads Guilty To Bextra Charges

Law360, New York (April 6, 2009, 12:00 AM EDT) -- Two months after Pfizer Inc. agreed to pay $2.3 million to settle allegations that it improperly marketed the now-defunct anti-inflammatory drug Bextra, a regional manager responsible for sales of the former blockbuster has agreed to plead guilty to distribution of a misbranded drug.

Branchburg, N.J.-resident Mary Holloway, 47, pled guilty to the one count of information misdemeanor in the U.S. District Court for the District of Massachusetts, the U.S. Attorney's Office said Thursday.

The office described Holloway as a regional manager at "a pharmaceutical company," and...
To view the full article, register now.